Clinical Trial: A Study to Learn More About Tukysa Once it is Out in the Korean Market

U.S., March 13 -- ClinicalTrials.gov registry received information related to the study (NCT06873191) titled 'A Study to Learn More About Tukysa Once it is Out in the Korean Market' on March 06.

Brief Summary: The objectives of the re-examination system in Korea is to re-confirm the clinical usefulness of the product through collecting, reviewing, identifying and verifying the safety and efficacy information about the product in general practice in Korea.

This surveillance is conducted for preparing application material for re-examination under the Pharmaceutical Affairs Laws, the Regulations on Safety of Pharmaceuticals, etc. and the Re-examination Regulation for New Drugs and Others.

Study Start Date: March 31

Study Type: OBSERVATIONA...